August 4, 2016
Three Japanese scientific societies are soon to launch a new organization for hereditary breast and ovarian cancer syndrome (HBOC), looking to forge a nationwide database on BRCA gene mutations - the target of novel molecular-targeted drugs called PARP inhibitors. The...read more